INDUCTION OF GRAFT-VERSUS-HOST DISEASE AFTER AUTOLOGOUS BONE MARROW TRANSPLANTATION

Richard J. Jones; Allan D. Hess; Risa B. Mann; Steven Piantadosi; Georgia B. Vogelsang; Evan R. Farmer; Robert B. Geller; George W. Santos

doi:10.1016/S0140-6736(89)92575-0

INDUCTION OF GRAFT-VERSUS-HOST DISEASE AFTER AUTOLOGOUS BONE MARROW TRANSPLANTATION

Richard J. Jones, Allan D. Hess, Risa B. Mann, Steven Piantadosi, Georgia B. Vogelsang, Evan R. Farmer, Robert B. Geller, George W. Santos

School of Medicine

Research output: Contribution to journal › Article › peer-review

168 Scopus citations

Abstract

To induce graft-versus-host disease (GvHD) in patients undergoing autologous bone marrow transplantation (BMT), five consecutive patients with non-Hodgkin lymphoma or Hodgkin's disease in resistant relapse were treated with cyclophosphamide and total body irradiation or busulphan and cyclophosphamide, followed by autologous BMT. The patients received cyclosporin 1 mg/kg per day intravenously for 28 days after BMT. Histologically proven grade II acute GvHD of the skin developed in all the patients at a median of 11 days (range 9-13) after BMT. One patient died and the GvHD resolved in 1-3 weeks in the four remaining patients- spontaneously in two and with corticosteroid treatment in two. Lymphocytes from one patient obtained at the time of GvHD were cytotoxic for the patient's own pretransplant lymphocytes. Cytotoxicity was blocked by antibodies directed against class II histocompatibility (HLA-DR or Ia) antigens. Cyclosporin-induced GvHD after autologous BMT resembles mild GvHD after allogeneic grafting. This syndrome appears to be mediated by autoreactive Iaspecific lymphocytes.

Original language	English (US)
Pages (from-to)	754-757
Number of pages	4
Journal	The Lancet
Volume	333
Issue number	8641
DOIs	https://doi.org/10.1016/S0140-6736(89)92575-0
State	Published - Apr 8 1989

ASJC Scopus subject areas

General Medicine

Access to Document

10.1016/S0140-6736(89)92575-0

Cite this

@article{f4078467a8d74b4d97b2f7ce7ffbcf3b,

title = "INDUCTION OF GRAFT-VERSUS-HOST DISEASE AFTER AUTOLOGOUS BONE MARROW TRANSPLANTATION",

abstract = "To induce graft-versus-host disease (GvHD) in patients undergoing autologous bone marrow transplantation (BMT), five consecutive patients with non-Hodgkin lymphoma or Hodgkin's disease in resistant relapse were treated with cyclophosphamide and total body irradiation or busulphan and cyclophosphamide, followed by autologous BMT. The patients received cyclosporin 1 mg/kg per day intravenously for 28 days after BMT. Histologically proven grade II acute GvHD of the skin developed in all the patients at a median of 11 days (range 9-13) after BMT. One patient died and the GvHD resolved in 1-3 weeks in the four remaining patients- spontaneously in two and with corticosteroid treatment in two. Lymphocytes from one patient obtained at the time of GvHD were cytotoxic for the patient's own pretransplant lymphocytes. Cytotoxicity was blocked by antibodies directed against class II histocompatibility (HLA-DR or Ia) antigens. Cyclosporin-induced GvHD after autologous BMT resembles mild GvHD after allogeneic grafting. This syndrome appears to be mediated by autoreactive Iaspecific lymphocytes.",

author = "Jones, {Richard J.} and Hess, {Allan D.} and Mann, {Risa B.} and Steven Piantadosi and Vogelsang, {Georgia B.} and Farmer, {Evan R.} and Geller, {Robert B.} and Santos, {George W.}",

note = "Funding Information: This work was supported partly by National Institutes of Health Grants CA15396 and AI24319. G. B. V. is a special fellow and A. D. H. is a scholar of the Leukaemia Society of America.",

year = "1989",

month = apr,

day = "8",

doi = "10.1016/S0140-6736(89)92575-0",

language = "English (US)",

volume = "333",

pages = "754--757",

journal = "The Lancet",

issn = "0140-6736",

publisher = "Elsevier Limited",

number = "8641",

}

TY - JOUR

T1 - INDUCTION OF GRAFT-VERSUS-HOST DISEASE AFTER AUTOLOGOUS BONE MARROW TRANSPLANTATION

AU - Jones, Richard J.

AU - Hess, Allan D.

AU - Mann, Risa B.

AU - Piantadosi, Steven

AU - Vogelsang, Georgia B.

AU - Farmer, Evan R.

AU - Geller, Robert B.

AU - Santos, George W.

N1 - Funding Information: This work was supported partly by National Institutes of Health Grants CA15396 and AI24319. G. B. V. is a special fellow and A. D. H. is a scholar of the Leukaemia Society of America.

PY - 1989/4/8

Y1 - 1989/4/8

N2 - To induce graft-versus-host disease (GvHD) in patients undergoing autologous bone marrow transplantation (BMT), five consecutive patients with non-Hodgkin lymphoma or Hodgkin's disease in resistant relapse were treated with cyclophosphamide and total body irradiation or busulphan and cyclophosphamide, followed by autologous BMT. The patients received cyclosporin 1 mg/kg per day intravenously for 28 days after BMT. Histologically proven grade II acute GvHD of the skin developed in all the patients at a median of 11 days (range 9-13) after BMT. One patient died and the GvHD resolved in 1-3 weeks in the four remaining patients- spontaneously in two and with corticosteroid treatment in two. Lymphocytes from one patient obtained at the time of GvHD were cytotoxic for the patient's own pretransplant lymphocytes. Cytotoxicity was blocked by antibodies directed against class II histocompatibility (HLA-DR or Ia) antigens. Cyclosporin-induced GvHD after autologous BMT resembles mild GvHD after allogeneic grafting. This syndrome appears to be mediated by autoreactive Iaspecific lymphocytes.

AB - To induce graft-versus-host disease (GvHD) in patients undergoing autologous bone marrow transplantation (BMT), five consecutive patients with non-Hodgkin lymphoma or Hodgkin's disease in resistant relapse were treated with cyclophosphamide and total body irradiation or busulphan and cyclophosphamide, followed by autologous BMT. The patients received cyclosporin 1 mg/kg per day intravenously for 28 days after BMT. Histologically proven grade II acute GvHD of the skin developed in all the patients at a median of 11 days (range 9-13) after BMT. One patient died and the GvHD resolved in 1-3 weeks in the four remaining patients- spontaneously in two and with corticosteroid treatment in two. Lymphocytes from one patient obtained at the time of GvHD were cytotoxic for the patient's own pretransplant lymphocytes. Cytotoxicity was blocked by antibodies directed against class II histocompatibility (HLA-DR or Ia) antigens. Cyclosporin-induced GvHD after autologous BMT resembles mild GvHD after allogeneic grafting. This syndrome appears to be mediated by autoreactive Iaspecific lymphocytes.

UR - http://www.scopus.com/inward/record.url?scp=0024547804&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0024547804&partnerID=8YFLogxK

U2 - 10.1016/S0140-6736(89)92575-0

DO - 10.1016/S0140-6736(89)92575-0

M3 - Article

C2 - 2564566

AN - SCOPUS:0024547804

SN - 0140-6736

VL - 333

SP - 754

EP - 757

JO - The Lancet

JF - The Lancet

IS - 8641

ER -

INDUCTION OF GRAFT-VERSUS-HOST DISEASE AFTER AUTOLOGOUS BONE MARROW TRANSPLANTATION

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this